|
PRESS RELEASES
RAYMEDICA® TO LAUNCH A NEW PATIENT FOCUSED
WEBSITE
MINNEAPOLIS- May 1, 2007 - Raymedica,
the Pioneer in Nucleus Arthroplasty, located in Minneapolis, Minnesota,
is pleased to announce the launch of a brand new website, www.hydraflexnas.com
to further the company’s position as the leader in Nucleus Arthroplasty™
Technology. The patient focused website presents information about a
new clinical study using the HydraFlex™ Nucleus Arthroplasty System™.
HydraFlex NAS™ is a surgical procedure utilizing a total-technology
system incorporating a device, coupled with special instrumentation
for implant, for the treatment of degenerative disc disease (DDD).
“The whole idea is to put the enormous amount of patient information
we have on the HydraFlex Nucleus Arthroplasty Technology into a single
managed website,” stated John J. Viscogliosi, Chairman and CEO
of Raymedica. Mr. Viscogliosi added, “We want to provide patient
information that is available from our vast resources. There is no single
website I know of that has the breadth of content Raymedica has available
in Nucleus Arthroplasty.”
About Raymedica
Raymedica, based in Minneapolis, Minnesota, is the Pioneer in Nucleus
Arthroplasty having developed the world’s first nucleus replacement
device in 1996. Raymedica develops, manufactures and markets medical
device systems designed to treat patients with degenerative disc disease
that have been unresponsive to non-surgical treatment. Raymedica’s
products are currently available in many countries worldwide, but are
limited to investigational use only in the United States. For more information,
visit the Company's website at http://www.raymedica.com.
About
Viscogliosi Bros., LLC
Established by Marc R. Viscogliosi, John J. Viscogliosi and Anthony
G. Viscogliosi in New York City in 1999, Viscogliosi Bros., LLC (VB)
was the first venture capital/private equity and merchant banking firm
dedicated to the musculoskeletal/orthopedics sector of the health care
industry.
Today, VB is a leading independent firm with a mission to create, build
and finance companies founded on innovations developed by surgeons and
uniquely focused on "life changing" musculoskeletal/orthopedic
technologies. VB has worldwide surgeon, industry and trade relationships
and significant financial expertise in the musculoskeletal/orthopedic
sector.
As principals of VB, the Viscogliosi brothers have a combined total
of nearly half a century of experience analyzing and investing in the
musculoskeletal/orthopedics sector, directing literally billions of
dollars through the orthopedics industry. They have pioneered
innovative financial, strategic and management initiatives for nearly
150 companies in the sector, from start-up, seed and development stage
all the way to exit, while helping thousands of people lead better lives
through the orthopedic and spinal products marketed and sold by the
companies they have assisted in developing and financing.
> Back to Press Releases
|
